Literature DB >> 23872833

Genomic testing: the clinical laboratory perspective.

H Faruki1.   

Abstract

The expansion of genetic testing in the clinical laboratory is well under way, with many clinically validated genetic tests already in use. As sequencing technology becomes more efficient and less costly, clinical laboratories will make the transition from single-gene testing to multigene panels. Early, more targeted applications will gradually be replaced by more comprehensive genomic offerings, including exome and whole-genome analysis. Despite significant technological advancements, many obstacles remain for full incorporation of whole-genome testing.

Mesh:

Year:  2013        PMID: 23872833     DOI: 10.1038/clpt.2013.61

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

1.  Evaluation of laboratory perspectives on hereditary cancer panels.

Authors:  Jessica Stoll; Scott M Weissman; Nicole Hook; Christina Selkirk; Amy Knight Johnson; Anna Newlin; Kristen J Vogel Postula
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

2.  Genomic medicine, precision medicine, personalized medicine: what's in a name?

Authors:  D M Roden; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2013-08       Impact factor: 6.875

3.  Genomic sequencing: assessing the health care system, policy, and big-data implications.

Authors:  Kathryn A Phillips; Julia R Trosman; Robin K Kelley; Mark J Pletcher; Michael P Douglas; Christine B Weldon
Journal:  Health Aff (Millwood)       Date:  2014-07       Impact factor: 6.301

Review 4.  Clinical implementation of germ line cancer pharmacogenetic variants during the next-generation sequencing era.

Authors:  N K Gillis; J N Patel; F Innocenti
Journal:  Clin Pharmacol Ther       Date:  2013-10-17       Impact factor: 6.875

5.  The business of genomic testing: a survey of early adopters.

Authors:  James M Crawford; Lynn Bry; John Pfeifer; Samuel K Caughron; Stephen Black-Schaffer; Jeffrey A Kant; Jill H Kaufman
Journal:  Genet Med       Date:  2014-07-10       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.